Narrow Results

Benitec MOU with Biomics Biotechnologies China.

Arkema & Aussie Chemeq Sign Manufacturing Cooperation Agreement.

AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimer's Disease.

Avexa Gets CSIRO Investment.

Living Cell Technologies' Encapsulated Choroid Plexus Cells May Be Used To Treat Hearing Loss.

Sundia MediTech Acquires Protein Folding Technology.

Beijing Cancer Hospital Introduces Fast and Precise RapidArc Radiotherapy Cancer Treatments.

Zydus Cadila and Karo Bio's Research Collaboration has Generated Promising Lead Compounds.

ICON Acquires Veeda Laboratories Limited.

Novavax-Cadila to Conduct Swine Flu Clinical Trials.

Axygen & Astellas form JV to Develop Protein Drugs.

Rexahn, KRICT to Develop Anti-Cancer Drugs.

Japan's Largest Pharmaceutical Firm Opens Regional HQ in Singapore.

Mono or diamino phthalocyanines with A3B or crosswise ABAB substitution patterns have been synthesized and used as building blocks for the preparation of dimeric and polymeric phthalocyanines. For this, 4,5-di(dodecylsulfanyl) phthalonitrile was converted into 1,3-diimino-6,7-di-(n-dodecylsulfanyl)-isoiminoindoline and then reacted with 6-nitro-1,3,3-trichloroisoindoline. The nitro functions on the resulting inseparable mixture of A3B and ABAB phthalocyanines were reduced into amines by Na₂S and the phthalocyanines could be chromatographically separated. Dimeric phthalocyanine was synthesized by the reaction of the mono-amino AB3 with sebacoyldichloride, and a poorly soluble linear polymeric material was obtained by reaction of the ABAB di-amino phthalocyanine with sebacoyl dichloride.